Value of Peptide Receptor Radionuclide Therapy as Neoadjuvant Treatment in the Management of Primary Inoperable Neuroendocrine Tumors
IntroductionNeuroendocrine neoplasms including neuroendocrine tumors (NETs) are often diagnosed as primary disseminated or inoperable. In those cases, systemic extensive therapy is necessary, but radical treatment is unlikely. As described in the literature, in some selected cases, peptide receptor...
Saved in:
Main Authors: | Marta Opalińska, Anna Sowa-Staszczak, Anna Grochowska, Helena Olearska, Alicja Hubalewska-Dydejczyk |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/1254a0f6a8cc42f8becf30fad0bed1c7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Approach to Neuroendocrine Neoplasm Associated With Ovarian Teratoma
by: Marta Opalińska, et al.
Published: (2021) -
A Novel Strategy for the Diagnosis of Pulmonary High-Grade Neuroendocrine Tumor
by: Kentaro Miura, et al.
Published: (2021) -
Imaging of Neuroendocrine Prostatic Carcinoma
by: Ahmed Taher, et al.
Published: (2021) -
Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours
by: Marianne S. Elston, et al.
Published: (2021) -
Prevalence of Neuroendocrine Tumors in the Gastrointestinal and Hepatobiliary Systems
by: Modesto J Varas Lorenzo, et al.
Published: (2019)